ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,422, issued on April 29, was assigned to Novartis AG (Basel, Switzerland).
"Uses of piperidinyl-indole derivatives" was invented by Jorg Eder (Rheinfelden, Germany), Richard Alexander Harrison (Shropshire, Great Britain), Boerje Haraldsson (Riehen, Switzerland) and Anna Svenja Shchubart Wellensiek (Basel, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the novel use of certain piperidinyl-indole derivatives in the treatment of patients suffering from renal diseases or disorders, and in particular for the treatment of patients suffering from C3G (C3 glomerulopathy) and IgAN (IgA nephropathy)."
The patent wa...